NIAID scientists and colleagues revealed new tethering mechanism in a gram-negative cell envelope
On Nov. 3, 2020, NIAID researchers and colleagues announced they had discovered a mechanism that some bacteria, such…
Neighborhood conditions associated with children’s cognitive function
On Nov. 3, 2020, a study published in JAMA Network Open showed that children from poorer neighborhoods performed…
Biotechnology | COVID-19 | Medicine | NIH | Therapeutics | Vaccine
Medigen Vaccines and NIHE partnered to develop COVID-19 vaccine in Vietnam
On Nov. 3, 2020, Medigen Vaccine Biologics (MVC) and the National Institute of Hygiene and Epidemiology (NIHE), a…
Humanigen executed licensing agreement for Lenzilumab in COVID-19 for South Korea and the Philippines
On Nov. 3, 2020, Humanigen announced the execution of its first licensing transaction in the Asia-Pacific Region with…
Biotechnology | COVID-19 | FDA
OraSure’s DNA Genotek subsidiary received FDA EUA for its ORAcollect-RNA saliva collectiondevice for SARS CoV-2
On Nov. 3, 2020, OraSure Technologies announced its DNA Genotek subsidiary has received Emergency Use Authorization from the…
Novavax announced facility expansion to support global vaccine development
On Nov. 2, 2020, Novavax announced the expansion of its Maryland campus to accommodate the company’s rapid growth…
CureVac reported positive interim phase 1 data for COVID-19 vaccine candidate
On Nov. 2, 2020, CureVac announced positive interim data from its ongoing Phase 1 dose-escalation study evaluating the…
Innovation Pharmaceuticals received pre-IND response from FDA on COVID-19 trial
On Nov. 2, 2020, Innovation Pharma announced receipt of written feedback from the FDA that is in general…
Immunic announced 200 patients enrolled in phase 2 CALVID-1 trial of IMU-838 for treatment of COVID-19
On Nov. 2, 2020, Immunic announced that the company had enrolled and randomized 200 patients, pre-specified in the…
Walgreens Boots Alliance and McKesson completed formation of German wholesale joint venture
On Nov. 2, 2020, Walgreens Boots Alliance (WBA) and McKesson announced the completion of their previously announced agreement…
COVID-19 pandemic sparked 3D printing engineering innovation
On Nov. 2, 2020, Pacific Northwest National Laboratory (PNNL) announced that in the Spring of 2020, as news…
ACON Laboratories announced the launch of its Flowflexﾙ Antigen COVID-19 test
On Nov. 2, 2020, ACON Laboratories announced the launch of its Flowflexﾙ SARS-COV-2 Antigen Rapid Test. The Flowflex…
Patriot Express Travel at BWI, SEATAC required on-site, rapid COVID-19 testing
On Nov. 1, 2020, the U.S. Department of Defense announced the start of rapid, on-site COVID-19 testing for…
Brilacidin exhibited potent in vitro antiviral activity against SARS-CoV-2
On Nov. 1, 2020, scientists announced that increasing evidence shows that both natural and synthetic antimicrobial peptides (AMPs),…
389,000 BinaxNOW COVID-19 tests distributed to historically black colleges and universities
On Oct. 31, 2020, the U.S. Department of Health and Human Services (HHS) announced that 389,040 state-of-the-art Abbott…
InBios awarded $12.7M to boost production of two COVID-19 diagnostics
On Oct. 31, 2020, the U.S. Department of Health and Human Services and the U.S. Department of Defense…
The CDC issued framework for resuming safe and responsible cruise ship passenger operations
On Oct. 30, 2020, the Centers for Disease Control and Prevention (CDC) issued a Framework for Conditional Sailing…
Kaiser Permanente Research Institute enrolled volunteers in a phase 3 clinical trial to evaluate COVID-19 vaccine
On Oct. 30, 2020, Kaiser Permanente Washington Health Research Institute (KPWHRI) announced enrollment of volunteers in a phase…
Trials of University of Oxford’s Coronavirus vaccine began in Kenya
On Oct. 30, 2020, the University of Oxford announced that Kenya had joined the global efforts in search…
Humanigen announced first patient dosed in phase 3 clinical study of Lenzilumab in COVID-19
On Oct. 30, 2020, Humanigen announced that MedStar Washington Hospital Center in Washington, D.C. treated its first COVID-19…
Hologic awarded US Government contract to expand COVID-19 test production capacity
On Oct. 30, 2020, Hologic announced that it had been awarded a $119 million contract from the U.S….
Innovation Pharma and George Mason University released lab testing results for Brilacidinﾒs COVID-19 treatment
On Oct. 30, 2020, Innovation Pharma and George Mason University jointly announced completion of extensive laboratory testing supporting…
REGN-COV2 IDMC recommended holding enrollment in hospitalized patients with high oxygen requirements
On Oct. 30, 2020, Regeneron announced that ot had received a recommendation from the independent data monitoring committee…
Icosavax launched COVID-19 vaccine program with preclinical data and $165 million in new funding
On Oct. 30, 2020, Icosavax announced the launch of the companyﾒs COVID-19 vaccine program with preclinical data on…
HHS and DOD announced $12.7 million contract with InBios to boost US production of rapid COVID-19 tests
On Oct. 30, 2020, the U.S. Department of Health and Human Services (HHS) and the U.S. Department of…
InBios awarded $12.67 million DOD contract to Increase domestic production of rapid point of care COVID-19 tests
On Oct. 30, 2020 InBios announced that it had received Emergency Use Authorization from the U.S. Food and…
The CDC opened new South America Regional Office in Brazil
On Oct. 29, 2020, the Centers for Disease Control and Prevention (CDC) opened its new South America regional…
Oxford University began COVID-19 test for individuals without symptoms
On Oct. 29, 2020, the University of Oxford announced a new pilot scheme to assess the use of…
Mammoth Biosciences announced agreements targeting high-throughput CRISPR-based SARS CoV-2 test
On Oct. 29, 2020, Mammoth Biosciences announced that it had signed agreements with MilliporeSigma and Hamilton Company targeting…
OncoSec announced FDA clearance of IND application for phase 1 clinical trial of CORVax12 vaccine candidate for COVID-19
On Oct. 29, 2020, OncoSec Medical announced that the FDA had approved the Investigational New Drug (IND) application…